This finding suggests that ADC promotes the initiation and expansion of T cells by promoting the antigen uptake of DCs and the migration to tumor-draining lymph nodes, which leads to increased infiltration of CD8+ T cells in the tumor microenvironment, thereby promoting the efficacy of immunotherapy. The gene discussed is CD8A; the disease is neoplasm.